| | |
| Clinical data | |
|---|---|
| ATCvet code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C107H138Cl2N26O31 |
| Molar mass | 2355.33 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Enramycin (also known as enduracidin) is a polypeptide antibiotic produced by Streptomyces fungicidus . Enramycin is widely used as a feed additive for pigs and chickens to prevent necrotic enteritis induced by Gram-positive gut pathogens. [1]
Enramycin acts as an inhibitor of the enzyme MurG, which is essential for cell wall biosynthesis in Gram-positive bacteria. MurG catalyzes the transglycosylation reaction in the last step of peptidoglycan biosynthesis. Inhibiting this step greatly compromises cell wall integrity leading to cell lysis. [2]
Enramycin has been found to be very effective against Gram-positive gut pathogens, most notably, Clostridium perfringens ; a leading cause of necrotic enteritis.[ citation needed ] The following represents MIC data for a couple of veterinary pathogens. [3]
Standard grade enramycin is composed of two main components called enramycin A and enramycin B. These two components are routinely used as analytical reference standards; however, their activity as individual compounds does not appear to be widely studied or characterized. [4]